The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Investigators hypothesize that high-dose n-3 polyunsaturated fatty acids (PUFA) oral supplementation will improve systemic inflammation, vascular function, and symptomatic status of patients with PAD. Investigators will explore novel mechanistic pathways by which n-3 PUFA affect PAD, evaluating the role of specialized lipid mediators involved in the resolution of inflammation.
Epistemonikos ID: bb656e5384d7c78b06d6816d47b4bef1d32b748f
First added on: May 11, 2024